Search research articles
Contact Us
Filters
Showing results (11-20 of 124) with videos related to
Page
of 13
Sort By:
Journal of Health, Population, and Nutrition
|
December 22, 2004
Evaluation of serogroup A meningococcal vaccines in Africa: a demonstration project
Montse Soriano-Gabarró, Nancy Rosenstein, F Marc LaForce
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 7, 2016
NCCN's Commitment to Medication Safety: The Vincristine Initiative
Jessica Sugalski, F Marc Stewart, Robert W Carlson
Human Vaccines & Immunotherapeutics
|
April 13, 2012
Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM)
Carl E Frasch, Marie-Pierre Preziosi, F Marc LaForce
Vaccine
|
May 30, 2009
Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution
F Marc LaForce, Neil Ravenscroft, Mamoudou Djingarey, et al.
Human Vaccines & Immunotherapeutics
|
October 20, 2017
Developmental strategy for a new Group A meningococcal conjugate vaccine (MenAfriVac<sup>R</sup>)
Prasad S Kulkarni, Suresh S Jadhav, F Marc LaForce
Nanoscale
|
February 21, 2024
Multivariate regression analysis of factors regulating the formation of synthetic aluminosilicate nanoparticles
Faisal T Adams, McNeill Bauer, Clément Levard, et al.
The Journal of Biological Chemistry
|
April 26, 2001
An invariant threonine is involved in self-catalyzed cleavage of the precursor protein for ornithine acetyltransferase
F Marc, P Weigel, C Legrain, et al.
Food Additives and Contaminants
|
October 9, 1998
Sorbic acid-amine function interactions
C Ferrand, F Marc, P Fritsch, et al.
Human Vaccines & Immunotherapeutics
|
October 3, 2017
Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps
F Marc LaForce, Mamoudou Djingarey, Simonetta Viviani, et al.
Viral Immunology
|
November 9, 2017
Lessons from the Meningitis Vaccine Project
F Marc LaForce, Mamoudou Djingarey, Simonetta Viviani, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 124) with videos related to
Sort By:
Page
of 13
Journal of Health, Population, and Nutrition
|
December 22, 2004
Evaluation of serogroup A meningococcal vaccines in Africa: a demonstration project
Montse Soriano-Gabarró, Nancy Rosenstein, F Marc LaForce
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 7, 2016
NCCN's Commitment to Medication Safety: The Vincristine Initiative
Jessica Sugalski, F Marc Stewart, Robert W Carlson
Human Vaccines & Immunotherapeutics
|
April 13, 2012
Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM)
Carl E Frasch, Marie-Pierre Preziosi, F Marc LaForce
Vaccine
|
May 30, 2009
Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution
F Marc LaForce, Neil Ravenscroft, Mamoudou Djingarey, et al.
Human Vaccines & Immunotherapeutics
|
October 20, 2017
Developmental strategy for a new Group A meningococcal conjugate vaccine (MenAfriVac<sup>R</sup>)
Prasad S Kulkarni, Suresh S Jadhav, F Marc LaForce
Nanoscale
|
February 21, 2024
Multivariate regression analysis of factors regulating the formation of synthetic aluminosilicate nanoparticles
Faisal T Adams, McNeill Bauer, Clément Levard, et al.
The Journal of Biological Chemistry
|
April 26, 2001
An invariant threonine is involved in self-catalyzed cleavage of the precursor protein for ornithine acetyltransferase
F Marc, P Weigel, C Legrain, et al.
Food Additives and Contaminants
|
October 9, 1998
Sorbic acid-amine function interactions
C Ferrand, F Marc, P Fritsch, et al.
Human Vaccines & Immunotherapeutics
|
October 3, 2017
Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps
F Marc LaForce, Mamoudou Djingarey, Simonetta Viviani, et al.
Viral Immunology
|
November 9, 2017
Lessons from the Meningitis Vaccine Project
F Marc LaForce, Mamoudou Djingarey, Simonetta Viviani, et al.
Page
of 13